Russell Investments Group’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $362K | Buy |
71,881
+7,042
| +11% | +$35.5K | ﹤0.01% | 2463 |
|
|
2025
Q1 | $420K | Buy |
64,839
+61,079
| +1,624% | +$396K | ﹤0.01% | 2357 |
|
|
2024
Q4 | $27.6K | Sell |
3,760
-16,839
| -82% | -$124K | ﹤0.01% | 2951 |
|
|
2024
Q3 | $154K | Sell |
20,599
-3,769
| -15% | -$28.2K | ﹤0.01% | 2567 |
|
|
2024
Q2 | $217K | Sell |
24,368
-1,603
| -6% | -$14.3K | ﹤0.01% | 2462 |
|
|
2024
Q1 | $263K | Buy |
25,971
+13,981
| +117% | +$142K | ﹤0.01% | 2383 |
|
|
2023
Q4 | $121K | Sell |
11,990
-13,654
| -53% | -$137K | ﹤0.01% | 2526 |
|
|
2023
Q3 | $240K | Buy |
25,644
+24,907
| +3,380% | +$233K | ﹤0.01% | 2451 |
|
|
2023
Q2 | $18.1K | Sell |
737
-1,963
| -73% | -$48.2K | ﹤0.01% | 2858 |
|
|
2023
Q1 | $62.8K | Sell |
2,700
-16,300
| -86% | -$379K | ﹤0.01% | 2678 |
|
|
2022
Q4 | $481K | Buy |
19,000
+9,169
| +93% | +$232K | ﹤0.01% | 2303 |
|
|
2022
Q3 | $186K | Buy |
9,831
+2,800
| +40% | +$53K | ﹤0.01% | 2557 |
|
|
2022
Q2 | $181K | Sell |
7,031
-37,638
| -84% | -$969K | ﹤0.01% | 2561 |
|
|
2022
Q1 | $1.15M | Buy |
44,669
+22,127
| +98% | +$569K | ﹤0.01% | 1892 |
|
|
2021
Q4 | $942K | Buy |
22,542
+16,691
| +285% | +$697K | ﹤0.01% | 2179 |
|
|
2021
Q3 | $253K | Sell |
5,851
-21,144
| -78% | -$914K | ﹤0.01% | 2700 |
|
|
2021
Q2 | $1.28M | Sell |
26,995
-10,635
| -28% | -$502K | ﹤0.01% | 2188 |
|
|
2021
Q1 | $1.93M | Sell |
37,630
-8,574
| -19% | -$439K | ﹤0.01% | 1891 |
|
|
2020
Q4 | $1.24M | Buy |
46,204
+12,234
| +36% | +$328K | ﹤0.01% | 2020 |
|
|
2020
Q3 | $1.17M | Buy |
33,970
+5,890
| +21% | +$202K | ﹤0.01% | 1996 |
|
|
2020
Q2 | $1.15M | Buy |
+28,080
| New | +$1.15M | ﹤0.01% | 1974 |
|